GHRSGH Research PLC

HealthcareUSD
$28.97

The financials

GH Research PLC by the numbers

GH Research PLC income statement, Q4 2025 against the same quarter a year earlier
Income statementQ4 2025Q4 2024Change
Operating income−$17M−$13Mn/a
Net income−$14M−$8.8Mn/a
Diluted EPS−$0.23−$0.17n/a

Biotechnology

Ranks #22 of 145 by Smart Score

Compare peers
ANAB+2.1%
AnaptysBio, Inc.
BCAX+2.7%
Bicara Therapeutics Inc.
ABSI+1.3%
Absci Corporation
ZYME-2.2%
Zymeworks Inc.
INVA-1.2%
Innoviva, Inc.
SNDX-0.85%
Syndax Pharmaceuticals, Inc.